Being overweight can increase the risk of developing multiple sclerosis and other autoimmune diseases.
The study showed that people with obesity, which means having a body mass index (BMI) over 30, are more likely to develop autoimmune diseases like rheumatoid arthritis, psoriasis, and multiple sclerosis. For example, the chance of getting multiple sclerosis is about 49% higher in those who are obese compared to those with a normal weight. This means that if you weigh more than what's considered healthy, you might need to be more careful about your health. The research looked at many studies to see how weight affects the risk of these diseases. Overall, it suggests that keeping a healthy weight can help lower the risk of autoimmune issues.
This finding is important for anyone with multiple sclerosis (MS) or other autoimmune diseases, as it highlights how weight can affect their health. If you or a loved one has MS, maintaining a healthy weight could be an easy step to help manage your condition better. Caregivers should also pay attention since they can support their loved ones in making healthier lifestyle choices. Health care providers can use this information to guide their patients towards better health practices. Just like how wearing a seatbelt helps keep you safe in a car, keeping a healthy weight can help protect against worsening autoimmune diseases.
The study has some limitations, as it looked at many different studies, which means results can vary. Not every individual case was studied in detail, so it’s important to talk with your doctor about your specific situation. Additionally, while the link between obesity and autoimmune diseases is clear, more research is needed to fully understand how weight affects these conditions.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Obesity (Silver Spring, Md.) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.